Cytokines as vaccine adjuvants: Interleukin 1 and its synthetic peptide 163–171
- 31 March 1993
- Vol. 11 (5) , 594-595
- https://doi.org/10.1016/0264-410x(93)90240-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The regulatory effects of cytokines on the induction of a peripheral immunologic tolerance in mice.The Journal of Immunology, 1990
- A monoclonal antibody to the IL-1 beta peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1 beta in vivo.The Journal of Immunology, 1989
- Lymphokine-activated tumor inhibition: Combinatory activity of a synthetic nonapeptide from interleukin-1, interleukin-2, interleukin-4, and interferon-γ injected around tumor-draining lymph nodesInternational Journal of Cancer, 1989
- In vivo restoration of T cell functions by human IL-1 beta or its 163-171 nonapeptide in immunodepressed mice.The Journal of Immunology, 1988
- In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta.The Journal of Experimental Medicine, 1988
- In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta.The Journal of Immunology, 1987
- A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity.The Journal of Immunology, 1986
- Cloning and expression of murine interleukin-1 cDNA in Escherichia coliNature, 1984
- The adjuvanticity of interleukin 1 in vivo.The Journal of Immunology, 1983